GeoPharma Inc. (GORX) Posts Q3 Loss of $0.19, Narrower Y/Y
GeoPharma Inc. (NASDAQ: GORX) reports Q3 loss of $0.19, compared to ($0.26) in the same quarter last year. Revenue for the quarter was $2.67 million, versus $4.57 million in Q309.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Semtech Corp (SMTC) Misses Q1 EPS by 4c; Guides Q2
- Mentor Graphics Corp (MENT) Beats Q1 EPS View by 5c; Lifts FY13 Outlook
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
